Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 11.918\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) N#Cc1c(-c2ccc(Br)cc2)cc(-c2cccnc2)nc1N
(b) CC1(C)CC(=O)C(C(C2=C(O)CC(C)(C)CC2=O)c2ccc(O)c([N+](=O)[O-])c2)=C(O)C1
(c) CC1(C)CC(O)C(CCC(O)c2ccccc2)C(C)(C)N1
Answer: c. CC1(C)CC(O)C(CCC(O)c2ccccc2)C(C)(C)N1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1(C)CC(O)C(CCC(O)c2ccccc2)C(C)(C)N1
CC1(C)CC(O)C(CCC(O)c2ccccc2)C(C)(C)N1
3-(3-hydroxy-3-phenylpropyl)-2,2,6,6-tetramethylpiperidin-4-ol